%0 Letter
%T [Glofitamab in relapsed and/or refractory diffuse large B cell lymphoma after at least two lines of treatment].
%A Daguerre V
%A Croizier C
%J Bull Cancer
%V 0
%N 0
%D 2024 Jun 13
%M 38876895
%F 1.318
%R 10.1016/j.bulcan.2024.02.016